Key result
Cardiac resynchronization therapy reduced all-cause mortality by 36% compared to conventional treatment in patients with recalcitrant heart failure.
Why the study?
Does cardiac resynchronization therapy improve outcomes in patients with recalcitrant heart failure?
Does cardiac resynchronization therapy improve outcomes in patients with recalcitrant heart failure?
This review highlights that CRT significantly improves cardiac function, quality of life, and survival in recalcitrant heart failure compared to conventional medical therapy, while emphasizing the importance of patient selection and surgical technique.
Answers are grounded in this paper and cite their sources.
May support CRT consideration in recalcitrant HF; leaves open the need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shi Wenqi (2025) conducted a review in Recalcitrant heart failure. Cardiac resynchronization therapy (CRT) vs. Conventional treatment methods was evaluated. Cardiac resynchronization therapy reduced all-cause mortality by 36% compared to conventional treatment in patients with recalcitrant heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: